Akiskal, HS, Bourgeois, ML, Angst, J et al (2000) Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. Journal of Affective Disorders, 59 (suppl 1): S5–30.
Berman, RM, Fava, M, Thase, ME et al (2009) Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants. CNS Spectrums, 14: 197–206.
Emsley, R, Chiliza, B, Asmal, L et al (2014) A randomized, controlled trial of omega-3 fatty acids plus an antioxidant for relapse prevention after antipsychotic discontinuation in first-episode schizophrenia. Schizophrenia Research, 158: 230–35.
Fisher, DS, Handley, SA, Flanagan, RJ et al (2012) Plasma concentrations of quetiapine, N-desalkylquetiapine, o-desalkylquetiapine, 7-hydroxy-quetiapine, and quetiapine sulfoxide in relation to quetiapine dose, formulation, and other factors. Therapeutic Drug Monitoring, 34: 415–21.
Frogley, C, Anagnostakis, K, Mitchell, S et al (2013) A case series of clozapine for borderline personality disorder. Annals of Clinical Psychiatry, 25: 125–34.
Hough, D, Gopal, S, Vijapurkar, U et al (2010) Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: a randomized, double-blind, placebo-controlled study. Schizophrenia Research, 116: 107–17.
Kane, J, Honigfeld, G, Singer, J et al (1988) Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Archives of General Psychiatry, 45: 789–96.
Kane, JM, Sanchez, R, Perry, PP et al (2012) Aripiprazole intramuscular depot as maintenance treatment in patients with schizophrenia: a 52-week, multicenter, randomized, double-blind, placebo-controlled study. Journal of Clinical Psychiatry, 73: 617–24.
Mezhebovsky, I, Magi, K, She, F et al (2013) Double-blind, randomized study of extended release quetiapine fumarate (quetiapine XR) monotherapy in older patients with generalized anxiety disorder. International Journal of Geriatric Psychiatry, 28: 615–25.
Suppes, T, Webb, A, Paul, B et al (1999) Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. American Journal of Psychiatry, 156: 1164–69.
Taylor, DM, Cornelius, V, Smith, L et al (2014) Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis. Acta Psychiatrica Scandinavica, 130: 452–69.
Taylor, D, Paton, C, Kapur, S (2015) Maudsley Prescribing Guidelines in Psychiatry (12th edn). Wiley-Blackwell.
Wunderink, L, Nieboer, RM, Wiersma, D et al (2013) Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial. JAMA Psychiatry, 70: 913–20.
Yeomans, D, Moncrieff, J, Huws, R (2015) Drug-centred psychopharmacology: a non-diagnostic framework for drug treatment. BJPsych Advances, 21: 229–36.
Zohar, J, Stahl, S, Moller, H-J et al (2014) Neuroscience-Based Nomenclature. Cambridge University Press.